BSECompany Update24 Aug 2026 · 24 Aug 2026, 03:08 pm
Akums Drugs and Pharmaceuticals Limited has informed the exchange about an update on schedule of the Investors/ Analysts Meet to be held on August 25, 2026
Akums Drugs and Pharmaceuticals Ltd · 544222
✦ AI SummaryMgmt Change
Akums Drugs and Pharmaceuticals Ltd has cancelled its participation in an Investors/Analysts Meet on August 25, 2026, due to medical reasons.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Akums Drugs and Pharmaceuticals Ltd - 544222 - Update On Schedule Of The Investors/Analysts Meet To Be Held On August 25, 2026
Attachments (1)
📄pdf
Download →
73dea697-4bca-4319-a4e5-a1383764767f.pdf
View document text
Ref: Akums/Exchange/2026-27/46 August 24, 2026
To, To,
The Listing Department The Listing Department
National Stock Exchange of India Ltd BSE Limited
Exchange Plaza, C-1, Block G, 25th Floor, New Trading Ring,
Bandra Kurla Complex, Rotunda Building, Phiroze Jeejeebhoy
Bandra (E), Mumbai – 400 051 Towers, Dalal Street, Mumbai – 400 001
Symbol: AKUMS Scrip Code: 544222
Sub: Update on Schedule of the Investors/Analysts Meet to be held on August 25, 2026
Respected Sir/Ma’am,
With reference to our earlier intimation bearing reference no. Akums/Exchange/2026-27/45 dated
August 13, 2026, we wish to inform you that the concerned personnel of Akums Drugs and
Pharmaceuticals Limited (the “Company”) will not be able to participate in the Investor/Analysts
Meet being organized by Antique Stock Broking Limited on August 25, 2026, at Trident, Bandra Kurla
Complex, Mumbai, due to medical reasons.
Accordingly, the participation of the Company in the said event stands cancelled.
This is for your information and records.
Thanking You
Yours Faithfully
For Akums Drugs and Pharmaceuticals Limited
Dharamvir Malik
Company Secretary & Compliance Officer